Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
for
Neovascular Age-related Macular Degeneration
Location: Portland ME, Little Silver NJ, Philadelphia PA,
Sponsor: AbbVie
Sex: All
Age: 50+
Code: NCT07007065
Phase3, Recruiting
Featured
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400
A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo, or Hidradenitis Suppurativa
for
Non-Segmental Vitiligo (NSV), Alopecia Areata,
Location: Fredericton, Pointe-Claire, Markham, Richmond Hill,
Sponsor: AbbVie
Sex: All
Age: 12+
Code: NCT07136467
Recruiting
Featured
A Study to Assess the Safety and Efficacy of AGN-151586 Injections for the Treatment of Moderate to Severe Forehead Lines (FHL) in Adult Participants
for
Forehead Lines
Location: New York NY, Wilmington NC, Pflugerville TX,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07730554
Phase2, Recruiting
Featured
A Study to Evaluate the Safety and Effectiveness of Upadacitinib in Pediatric Participants With Alopecia Areata
for
Severe Alopecia Areata
Location: Miami FL, Fairborn OH, Indianapolis IN, Omaha NE,
Sponsor: AbbVie
Sex: All
Age: 6 - 17
Code: NCT07772492
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Featured
A Study to Assess the Adverse Events and How Oral Emraclidine Moves Through the Body of Healthy Elderly Adult Participants
for
Healthy Volunteer
Location: Marlton NJ, Miami FL, Maitland FL, Grayslake IL
Sponsor: AbbVie
Sex: All
Age: 65 - 70+
Code: NCT07219030
Phase1, Recruiting
Featured
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
for
Epithelial Ovarian Cancer, Fallopian Tube Cancer,
Location: Providence RI, New Haven CT, Lebanon NH, Bay Shore NY,
Sponsor: AbbVie
Sex: Female
Age: 18+
Code: NCT06890338
Phase2, Recruiting
Featured
Study to Assess Change in Quality of Life of Risankizumab Treatment in Adult Participants With Moderate-to-Severe Plaque Psoriasis
A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
for
Colorectal Cancer
Location: New Haven CT, Lake Success NY, East Brunswick NJ,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07525206
Phase3, Recruiting
Featured
A Study to Assess Safety, Tolerability, and How Single and Multiple Injections or Infusions of ABBV-313 Affects the Body of Adult Participants
for
Healthy Volunteers
Location: Grayslake IL, Anaheim CA
Sponsor: AbbVie
Sex: All
Age: 18 - 55
Code: NCT07673120
Phase1, Recruiting
Featured
An Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis
for
Rheumatoid Arthritis
Location: Tamarac FL, Tomball TX, Lake Charles LA, Houston TX
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT07620392
Phase2, Recruiting
Featured
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO7663498 Following Intravitreal Administration in Participants With Diabetic Retinopathy
for
Diabetic Retinopathy
Location: Columbus OH, Oak Forest IL, Glendale CA
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT07588100
Phase1, Recruiting
Featured
A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease
for
Alzheimer's Disease
Location: Watertown MA, Wellington FL, Stuart FL, Winter Park FL,
Sponsor: AbbVie
Sex: All
Age: 50 - 70+
Code: NCT07599670
Phase1, Phase2, Recruiting
Featured
A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)
for
Acute Myeloid Leukemia
Location: Valhalla NY, Nashville TN, Dallas TX, Palo Alto CA
Sponsor: AbbVie
Sex: All
Age: 0 - 17
Code: NCT07306832
Phase1, Recruiting
Featured
A Study to Evaluate the Effect of Moderate or Severe Hepatic Impairment on the Pharmacokinetics (PK) of Inavolisib
for
Hepatic Impairment
Location: Orlando FL, San Antonio TX, Lake Forest CA
Sponsor: Genentech, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07144111
Phase1, Recruiting
Featured
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
for
Alzheimers Disease
Location: Halifax, Boston MA, Watertown MA, Newton MA,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 50 - 70+
Code: NCT07177352
Phase3, Recruiting
Featured
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
for
Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer
Location: Rimouski, Boston MA, Worcester MA, Hartford CT, Quebec,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT06793215
Phase3, Recruiting
Featured
RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive
for
HER2-positive Breast Cancer
Location: Shirley NY, Quebec, Albany NY, East Brunswick NJ,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT07413939
Phase2, Phase3, Recruiting
Featured
A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia
for
Schizophrenia
Location: Marlton NJ, Gaithersburg MD, Little Rock AR,
Sponsor: AbbVie
Sex: All
Age: 18 - 65
Code: NCT07145918
Phase2, Recruiting
Featured
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
for
Multiple Myeloma
Location: Boston MA, New Haven CT, New York NY, Chapel Hill NC,